Crick team awarded $1m to tackle cancer drug resistance
Julian Downward, Principal Group Leader of the Oncogene Biology Laboratory at the Crick, has been awarded $1m over three years from the Novartis Global Scholars Program (NGSP) to study drug resistance in cancer.
Published: 28 February 2024